Enalapril Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg
Reference Brands: Vasotec(US)
Category:
Medical Aid
Enalapril tablets are ACE inhibitors that block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Benefits include lowering blood pressure, reducing heart failure symptoms, preventing strokes, and protecting kidney function, thereby improving cardiovascular health and decreasing the risk of hypertension-related complications.
Enalapril tablets is available in Tablet
and strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Enalapril tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Enalapril tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Enalapril tablets are approved in both the US and EU, supported by detailed dossiers demonstrating safety, efficacy, and quality, compliant with GMP standards. In the US, they are regulated by the FDA, while in the EU, EMA oversees approval processes. These dossiers include clinical trial data, stability, and manufacturing information. Enalapril is widely prescribed for hypertension and heart failure, with market authorization based on rigorous evaluation. For comprehensive regulatory insights, licensing requirements, and approved dossiers for enalapril tablets, visit Pharmatradz. Stay informed about the latest updates on regulatory approvals and market access pathways for enalapril globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing